FMP
IDEAYA Biosciences, Inc.
IDYA
NASDAQ
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
23.14 USD
-0.01 (-0.04322%)
We are unable to load the chart at this time.
We are unable to load the chart at this time.
Date
Revenue
Earnings
Estimated Earnings
Surprise
2024-11-04
0
-0.6
-0.67
-10.45%
2024-08-06
0
-0.68
-0.55
23.64%
2024-05-07
0
-0.53
-0.53
0.00%
2024-02-20
3.92M
-0.52
-0.49
6.12%
2023-11-07
8.04M
-0.46
-0.47
-2.13%
2023-08-10
3.54M
-0.5
-0.53
-5.66%
2023-05-09
7.88M
-0.49
-0.51
-3.92%
2023-03-07
4.02M
-0.5
-0.57
-12.28%
2022-11-08
29.7M
0.04
-0.65
-106.15%
2022-08-15
5.85M
-0.57
-0.57
0.00%
2022-05-10
11.36M
-0.36
-0.41
-12.20%
2022-03-15
2.96M
-0.47
-0.31
51.61%
2021-11-15
8.98M
-0.31
-0.29
6.90%
2021-08-10
8.76M
-0.33
-0.07
371.43%
2021-05-10
7.25M
-0.28
-0.28
0.00%
2021-03-23
10.57M
-0.18
-0.18
0.00%
2020-11-12
8.97M
-0.17
1.34
-112.69%
2020-08-12
0
-0.59
2.24
-126.34%
2020-05-12
0
-0.59
-0.57
3.51%
2020-03-24
0
-0.53
-0.57
-7.02%
2019-11-13
0
-0.54
-0.67
-19.40%
2019-08-12
0
-1.3
-0.64
103.13%
2019-03-31
0
-0.49
0
-
2018-12-31
0
-0.6
0
-
2018-09-30
0
-0.92
0
-
2018-06-30
0
-0.49
0
-
2018-03-31
0
-0.4
0
-